Thus, to test the hypothesis that enhanced activation of the KISS1R signaling pathway plays a protective role in NAFLD, we used 2 HFD-fed mouse models of NAFLD, which were treated with KPA, a potent, protease-resistant KP analog (34). Here, KISS1R is linked to metabolic dysfunction-associated steatotic liver disease.